Muhammad Akbar Ramadhan Munandar; Hendra Priatna Munandar; Liana Herlina. Cost-Effectiveness of Pembrolizumab As First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review. the int. j. of med. science and health 2026, 23 (2), 64-130. https://doi.org/10.70070/h3zdy035.